ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,424, issued on Sept. 30, was assigned to RADIUS PHARMACEUTICALS INC. (Boston).
"Estrogen receptor-modulating compounds" was invented by Chris P. Miller (San Mateo, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors."
The patent was filed on July 21, 2020, under Application...